超选择性上腺动脉栓塞对原发性阿尔多斯顿症患者功能的影响:一项前性队列研究
相关实验视频
Updated: Jul 11, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.5K
Ze-Qun Lai1, Yang Fu1, Jian-Wei Liu1
1Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, China.
概括
在原发性阿尔多斯顿症 (PA) 患者中,超选择性上腺动脉栓塞 (SAAE) 导致估计的球透率 (eGFR) 略有下降. 在SAAE后早期的eGFR变化可以预测PA患者的长期功能结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 干预性放射学 干预性放射学
- 内分泌学 在内分泌学.
背景情况:
- 原发性阿尔多斯特隆症 (PA) 是一种经常用超选择性上腺动脉栓塞 (SAAE) 治疗的疾病.
- 在PA患者中,SAAE对功能的长期影响,特别是估计的膜过率 (eGFR),尚未完全理解.
研究的目的:
- 研究SAAE对PA患者eGFR的影响.
- 分析基线eGFR和球过状态如何影响SAAE对功能的影响.
- 为了确定早期SAAE后的eGFR变化是否可以预测长期结果.
主要方法:
- 一项前性队列研究,涉及182名PA患者接受SAAE治疗.
- 收集关于eGFR,年龄,性别,BMI和糖尿病特异性的eGFR残留物的数据.
- 分析了基线的eGFR变化,SAAE后24小时,以及8个月的中位数随访后.
主要成果:
- SAAE导致整体eGFR (91.9至88.7毫升/分钟/1.73米2) 显著下降.
- 基线eGFR≥90毫升/分钟/1.73米2的患者和球过的患者显示出显著的eGFR降低.
- 早期的eGFR变化 (24小时后SAAE) 预测了长期的eGFR变化.
结论:
- 在PA患者中,SAAE可能对功能产生不同的影响,这取决于基线eGFR和过状态.
- 虽然整体eGFR略有下降,但SAAE的影响有所变化,在基线eGFR或过率较高的患者中可能会出现下降.
- 在SAAE后监测早期的eGFR变化对于预测PA患者的长期功能轨迹至关重要.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
648
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
648
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
659
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
659
Antihypertensive Drugs: Angiotensin II Receptor Blockers
750
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
750
Acute Kidney Injury IV: Diagnostic Studies and Prevention
18
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
18
Hormonal Regulation
33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K

